Troy Wilson, Kura Oncology CEO
Kura plans to sell $100M of shares on the back of interim readout of acute myeloid leukemia drug
Kura Oncology intends to raise $100 million by selling shares, it announced Tuesday afternoon. The stock sale comes after the San …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
